Y. Chalandon

A. Gratwohl, H. Baldomero, J. Passweg, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis.

V. Rollason, P. Dayer, C. Combescure, 2014, The lancet. Psychiatry.

Atypical presentation of acute myeloid leukemia: cardiac myeloid sarcoma

J. Passweg, Y. Chalandon, F. Rigamonti, 2009, International journal of hematology.

Longer Intervals Between Hematopoietic Stem Cell Transplantation and Subsequent 90Y-Ibritumomab Radioimmunotherapy May Correlate With Better Tolerance

John O. Prior, O. Ratib, F. Buchegger, 2012, Clinical nuclear medicine.

Reconstitution of the immune system after hematopoietic stem cell transplantation in humans

J. Passweg, J. Storek, B. Huard, 2008, Seminars in Immunopathology.

Improvement of relative survival in elderly patients with acute myeloid leukaemia emerging from population-based cancer registries in Switzerland between 2001 and 2013.

V. Arndt, H. Baldomero, M. Gregor, 2018, Cancer Epidemiology.

Allogeneic stem cell transplantation in therapy-related myelodysplasia after autologous transplantation for lymphoma: a retrospective study of the SFGM-TC.

M. Robin, P. Chevallier, M. Mohty, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

E. Vellenga, M. Jongen‐Lavrencic, L. Michaux, 2020, Leukemia.

Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir

G. Papanicolaou, J. Terrier, C. van Delden, 2021, Antimicrobial Agents and Chemotherapy.

State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019

M. Robin, I. Yakoub-Agha, C. Harrison, 2019, Haematologica.

Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant R

J. Bourhis, G. Mufti, N. Kröger, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR.

S. Montoto, M. Perales, I. Yakoub-Agha, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP‐EBMT study

S. Montoto, I. Yakoub-Agha, D. Blaise, 2020, British journal of haematology.

Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin’s lymphoma undergoing allogeneic haematopoietic cell transplantation—a study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

I. Yakoub-Agha, D. Blaise, P. Rohrlich, 2018, Bone Marrow Transplantation.

Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL

H. Dombret, E. Macintyre, S. Spicuglia, 2019, Clinical Cancer Research.

Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT

A. Ganser, S. Iacobelli, M. Robin, 2021, Bone Marrow Transplantation.

Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus-leukemia reaction? A prospective phase II study.

B. Chapuis, Y. Chalandon, E. Roosnek, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Growth autonomy and lineage switching in BCR-ABL-transduced human cord blood cells depend on different functional domains of BCR-ABL

A. Eaves, Y. Chalandon, C. Eaves, 2004, Leukemia.

New Models to Investigate Mechanisms of Disease Genesis from Primitive BCR‐ABL+ Hematopoietic Cells

C. Eaves, Xiaoyan Jiang, E. Zanjani, 2003, Annals of the New York Academy of Sciences.

Combined radioimmunotherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations.

F. Buchegger, A. Pèlegrin, J. Mach, 1992, Anticancer research.

Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia

H. Dombret, F. Lacombe, E. Macintyre, 2010, Haematologica.

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome – positive acute lymphoblastic leukemia : results of the GRAAPH-2003 study

J. Cayuela, H. Dombret, E. Macintyre, 2006 .

Is Less Chemotherapy Detrimental in Adults with Philadelphia Chromosome (Ph)-Positive Acute Lymphoblastic Leukemia (ALL) Treated with High-Dose Imatinib? Results of the Prospective Randomized Graaph-2005 Study

J. Cayuela, H. Dombret, S. Leprêtre, 2012 .

First Results of the GRAAPH-2005 Study in younger Adult Patients with De Novo Philadelphia Positive Acute Lymphoblastic Leukemia

J. Cayuela, H. Dombret, S. Leprêtre, 2008 .

Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS.

M. Jongen‐Lavrencic, T. Pabst, G. Ossenkoppele, 2020, Blood advances.

Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections

F. Ruschitzka, C. Seiler, C. Lovis, 2016, BMC Infectious Diseases.

Bone marrow dosimetry in rats using direct tissue counting after injection of radio-iodinated intact monoclonal antibodies or F(ab')2 fragments.

F. Buchegger, A. Pèlegrin, J. Mach, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pre‐transplant donor‐specific HLA antibodies and risk for poor first‐year renal transplant outcomes: results from the Swiss Transplant Cohort Study

F. Ruschitzka, C. Lovis, S. De Geest, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

Quality of life and social integration after allogeneic hematopoietic SCT

R. Miralbell, J. Passweg, B. Chapuis, 2008, Bone Marrow Transplantation.

TAFRO Syndrome in Caucasians: A Case Report and Review of the Literature

D. Fajgenbaum, D. Launay, K. Samii, 2017, Frontiers in Medicine.

BCR-ABL-transduced human cord blood cells produce abnormal populations in immunodeficient mice

A. Eaves, Y. Chalandon, O. Christ, 2005, Leukemia.

Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study

S. Montoto, N. Kröger, M. Robin, 2021, Haematologica.

High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities

H. Baldomero, J. Passweg, D. Heim, 2015, Bone Marrow Transplantation.

Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland

A. Gratwohl, A. Tichelli, J. Tiercy, 2006, Bone Marrow Transplantation.

The Association of Combined GSTM 1 and CYP 2 C 9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation

Patricia Huezo-Diaz Curtis, Y. Daali, M. Krajinovic, 2018 .

The Association of Combined GSTM1 and CYP2C9 Genotype Status with the Occurrence of Hemorrhagic Cystitis in Pediatric Patients Receiving Myeloablative Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation

Y. Daali, M. Krajinovic, M. Ansari, 2017, Front. Pharmacol..

NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin

A. Pradier, Y. Chalandon, E. Roosnek, 2015, The Journal of Immunology.

Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT

K. Sułek, M. Aljurf, D. Niederwieser, 2018, Bone Marrow Transplantation.

Myelodysplastic/Myeloproliferative Neoplasms

Y. Chalandon, F. Onida, 2018, The EBMT Handbook.

Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

A. Ganser, G. Mufti, N. Kröger, 2015, British journal of haematology.

Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT

N. Kröger, M. Robin, I. Yakoub-Agha, 2021, Bone Marrow Transplantation.

Myeloproliferative Neoplasms

Y. Chalandon, N. Kröger, 2018, The EBMT Handbook.

N. Kröger, J. Sierra, M. Robin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reversible ventricular arrythmia induced by dasatinib

P. Morel, L. Gétaz, H. Spechbach, 2013, Clinical case reports.

Antilymphocyte globulin for matched sibling donor transplantation in patients with myelofibrosis

J. Bourhis, N. Kröger, C. Craddock, 2019, Haematologica.

In the present study, we have measured bone marrow radioactivity using direct counting of tissues from normal rats and from tumor-bearing nude rats after intravenous injection ofradiolabeled intact Mabs or F(ab')2 fragments

F. Buchegger, A. Pèlegrin, J. Mach, 2006 .

Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal

J. Passweg, Y. Chalandon, E. Roosnek, 2011, Bone Marrow Transplantation.

Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study

N. Mueller, J. Passweg, M. Weisser, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft

F. Giannotti, Y. Chalandon, S. Masouridi-Levrat, 2021, Bone Marrow Transplantation.

Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study.

J. Cayuela, H. Dombret, A. Delannoy, 2013, Biology of Blood and Marrow Transplantation.

Long-Term Results of the Imatinib GRAAPH-2003 Study in Newly-Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

J. Cayuela, H. Dombret, E. Macintyre, 2009 .

Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS

E. Vellenga, M. Jongen‐Lavrencic, M. Vekemans, 2021, Cancers.

FLT3‐ITD mutations do not impact the outcome of patients allografted with partial T‐cell depleted grafts for AML with normal cytogenetics in first complete remission

C. Dantin, Y. Chalandon, E. Roosnek, 2017, Hematological oncology.

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome

M. Jongen‐Lavrencic, M. Gregor, G. Ossenkoppele, 2022, Leukemia.

Successful Ovarian Stimulation for Fertility Preservation in a Patient with Chronic Myeloid Leukemia: Switch from Nilotinib to Interferon-α.

L. Perey, A. Rosselet, P. Mathevet, 2018, The oncologist.

Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trial

T. Buclin, L. Decosterd, M. Gregor, 2014, Cancer Chemotherapy and Pharmacology.

An EBMT Prospective Non-Interventional Study of Outcomes and Toxicity of Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Patients Previously Treated with Second Generation Tyrosine Kinase Inhibitors

A. Ganser, N. Kröger, S. Iacobelli, 2016 .

Steroid-responsive cauda equina syndrome associated with GVHD after allogeneic hematopoietic stem cell transplantation

J. Passweg, P. Burkhard, Y. Chalandon, 2008, Bone Marrow Transplantation.

Human carcinoembryonic antigen cDNA expressed in rat carcinoma cells can function as target antigen for tumor localization of antibodies in nude rats and as rejection antigen in syngeneic rats

K. Schwarz, D. Hayoz, Monique Martin, 1992, International journal of cancer.

Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation.

H. Einsele, N. Kröger, G. Ehninger, 2006, Blood.

Initial cord blood unit volume affects mononuclear cell and CD34+ cell-processing efficiency in a non-linear fashion.

V. Kindler, A. Gratwohl, J. Passweg, 2012, Cytotherapy.

CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells

J. Passweg, C. Dantin, C. Chizzolini, 2010, European journal of immunology.

Myeloablative and Reduced-intensity conditioned Allogeneic Haematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of EBMT.

N. Kröger, L. Kanz, M. Robin, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study

F. Ruschitzka, C. Seiler, C. Lovis, 2020, American Journal of Transplantation.

DEFIBROTIDE SHOWS EFFICACY IN THE PREVENTION OF SINUSOIDAL OBSTRUCTION SYNDROME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A RETROSPECTIVE STUDY ON 237 PATIENTS.

C. Dantin, M. Ansari, F. Giannotti, 2022, Transplantation and cellular therapy.

Cord blood banks collect units with different HLA alleles and haplotypes to volunteer donor banks: a comparative report from Swiss Blood stem cells

W. Holzgreve, V. Kindler, A. Gratwohl, 2009, Bone Marrow Transplantation.

The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable

A. Gratwohl, J. Passweg, D. Heim, 2007, Bone Marrow Transplantation.

Association of TNFd and IL-10 Polymorphisms with Mortality in Unrelated Hematopoietic Stem Cell Transplantation

A. Gratwohl, J. Passweg, J. Tiercy, 2006, Transplantation.

vitro and leukemogenic activity in vivo BCR-ABL show accelerated loss after culture of factor-independence in Primitive interleukin 3 null hematopoietic cells transduced with

C. Yip, Xiaoyan Jiang, Y. Chalandon, 2013 .

Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo.

C. Eaves, C. Yip, Xiaoyan Jiang, 2002, Blood.

Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT

M. Labopin, I. Yakoub-Agha, D. Blaise, 2022, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT

A. Ganser, N. Kröger, M. Robin, 2020, Bone Marrow Transplantation.

Tumor‐necrosis factor can enhance radio‐antibody uptake in human colon carcinoma xenografts by increasing vascular permeability

F. Buchegger, J. Mach, S. Folli, 1993, International journal of cancer.

Invasive microsporidiosis in allogeneic haematopoietic SCT recipients

K. Krause, J. Passweg, Y. Chalandon, 2010, Bone Marrow Transplantation.

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis

H. Einsele, N. Kröger, M. Robin, 2019, Haematologica.

High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation

A. Sanchez‐Mazas, H. Baldomero, J. Passweg, 2019, Bone Marrow Transplantation.

Third‐party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post‐hematopoietic stem cell transplantation

D. Strunk, V. Kindler, J. Passweg, 2012, Pediatric transplantation.

Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT

J. Johansson, N. Kröger, S. Iacobelli, 2020, British journal of haematology.

Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial

J. Passweg, M. Ansari, D. Heim, 2020, Annals of Hematology.

Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT

J. Passweg, M. Manz, G. Stussi, 2013, Bone Marrow Transplantation.

In-Hospital Transfer Is a Risk Factor for Invasive Filamentous Fungal Infection among Hospitalized Patients with Hematological Malignancies: A Matched Case-Control Study

A. Gayet-Ageron, D. Pittet, C. van Delden, 2015, Infection Control & Hospital Epidemiology.

Burden and Timeline of Infectious Diseases in the First Year After Solid Organ Transplantation in the Swiss Transplant Cohort Study

F. Ruschitzka, C. Seiler, C. Lovis, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients

C. Dantin, A. Pradier, F. Giannotti, 2021, Bone Marrow Transplantation.

Do NK Cells Contribute to the Pathophysiology of Transplant‐Associated Thrombotic Microangiopathy?

J. Passweg, A. Rougemont, F. Gumy-Pause, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Invasive Mold Infections in Allogeneic Hematopoietic Cell Transplant Recipients in 2020: Have We Made Enough Progress?

F. Giannotti, L. Kaiser, A. Poncet, 2021, Open forum infectious diseases.

Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation

C. Dantin, A. Pradier, M. Ansari, 2018, Leukemia & lymphoma.

Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation.

P. Bartolomeo, M. Robin, I. Yakoub-Agha, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

N. Kröger, M. Robin, I. Yakoub-Agha, 2015, British journal of haematology.

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT

S. Iacobelli, J. Finke, P. Ljungman, 2010, Bone Marrow Transplantation.

A Case of Drug-Induced Hepatitis due to Lenalidomide

L. Rubbia‐Brandt, L. Spahr, A. Hadengue, 2011, Case Reports in Gastroenterology.

[Indications and management of hematologic microtransplantation: Recommendations of the French Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].

P. Chevallier, I. Yakoub-Agha, C. Picard, 2020, Bulletin du cancer.

Benefit of Prestorage Leukocyte Depletion of Single–Donor Platelet Concentrates

P. Roux‐Lombard, J. Dayer, B. Chapuis, 1999, Vox Sanguinis.

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.

Bob Löwenberg, Carlos Graux, Nancy Boeckx, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation

F. Giannotti, C. van Delden, Y. Chalandon, 2021, Journal of fungi.

Therapeutic Drug Monitoring of Orally Administered Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplant Recipients

P. Lescuyer, A. Karmime, D. Tonoli, 2022, Antimicrobial agents and chemotherapy.

Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients.

N. Mueller, J. Passweg, C. van Delden, 2020, Medical mycology.

Invasive zygomycosis in transplant recipients

T. Berney, C. van Delden, K. Hadaya, 2007, Clinical transplantation.

Clinical Considerations of Isavuconazole Administration in High-Risk Hematological Patients: A Single-Center 5-Year Experience

C. van Delden, N. Vernaz, Y. Chalandon, 2021, Mycopathologia.

Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections

P. Bochud, F. Giannotti, L. Kaiser, 2021, Mycoses.

Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: A 5‐year analysis within the Swiss Transplant Cohort study

C. Combescure, N. Mueller, J. Passweg, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning

R. Porcher, J. Cayuela, M. Robin, 2012, Haematologica.

Risk factors for a severe form of COVID‐19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM‐TC) multicentre cohort study

M. Robin, J. Bay, C. Xhaard, 2021, British Journal of Haematology.

Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients

C. Combescure, J. Passweg, L. Kaiser, 2011, Haematologica.

Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients

John O. Prior, S. Larson, D. Speiser, 2013, Clinical & developmental immunology.

Granulocyte‐colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: A randomized trial

L. Rubbia‐Brandt, L. Spahr, J. Frossard, 2008, Hepatology.

Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

P. Chevallier, I. Yakoub-Agha, J. Bay, 2021, Journal of Cancer Research and Clinical Oncology.

Improved Outcome in Young Children Compared to Adolescents and Adults After Allogeneic Hematopoietic Stem Cell Transplant for Acute Myeloid Leukemia: a Retrospective Study From Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) (SFGM-TC)

P. Chevallier, I. Yakoub-Agha, J. Bay, 2021 .

Phosphonoformate Crystalluria, A Warning Signal of Foscarnet-Induced Kidney Injury

Y. Chalandon, T. Ernandez, C. Stoermann, 2020, Kidney international reports.

Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Decompensated Alcoholic Liver Disease: A Randomized Controlled Trial

N. Lanthier, L. Rubbia‐Brandt, V. Kindler, 2013, PloS one.

Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

J. Johansson, N. Kröger, C. Craddock, 2017, British journal of haematology.

Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion

Y. Chalandon, C. Helg, M. Stalder, 2004, European journal of haematology.

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.

H. Dombret, E. Macintyre, S. Leprêtre, 2011, Blood.

Thromboembolism Prophylaxis in Adult Patients with Acute Lymphoblastic Leukemia Treated in the GRAALL-2005 Study.

H. Dombret, P. Chevallier, T. Pabst, 2020, Blood.

Clonal heterogeneity and chromosomal instability at disease presentation in high hyperdiploid acute lymphoblastic leukemia.

A. Marazzi, Y. Chalandon, M. Jotterand, 2010, Cancer Genetics and Cytogenetics.

DNMT3A mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemia

H. Dombret, E. Macintyre, S. Leprêtre, 2019, Haematologica.

Targeting mutated protein tyrosine kinases and their signaling pathways in hematologic malignancies.

Y. Chalandon, J. Schwaller, 2005, Haematologica.

Long-term deregulated human hematopoiesis in goats transplanted in utero with BCR-ABL-transduced lin−CD34+ cord blood cells

C. Eaves, Mei-jue Chen, Z. Ren, 2013, Cell Research.

Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia.

J. Cayuela, H. Dombret, S. Leprêtre, 2015, Blood.

Modulation of p210(BCR-ABL) activity in transduced primary human hematopoietic cells controls lineage programming.

C. Eaves, G. Hazlewood, Xiaoyan Jiang, 2002, Blood.

PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study

J. D. Vos, P. Brousset, J. Soulier, 2009, Leukemia.

Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party.

N. Kröger, I. Yakoub-Agha, A. Nagler, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia.

J. Bourhis, H. Dombret, P. Chevallier, 2015, Blood.

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia.

J. Cayuela, H. Dombret, E. Macintyre, 2014, Blood.

Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial.

H. Dombret, E. Macintyre, S. Leprêtre, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.

H. Dombret, S. Chevret, P. Chevallier, 2016, The New England journal of medicine.

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

H. Dombret, E. Macintyre, A. Delannoy, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia.

H. Dombret, M. Béné, V. Eclache, 2017, Blood.

Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation.

B. Chapuis, Y. Chalandon, E. Roosnek, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation

H. Dombret, E. Macintyre, S. Leprêtre, 2020, Leukemia.

Transcriptome Identifies Mechanisms of 1 Regulatory T cell ( Treg ) Suppression of Acute Graft-versus-Host-Disease 2 3

Simonetta, S. Buhler, R. Negrin, 2022 .

Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation

Marc Ansari, C. Dantin, S. Buhler, 2019, Leukemia.

Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT

R. Fanin, P. Chiusolo, I. Yakoub-Agha, 2021, Bone Marrow Transplantation.

Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Geneva experience

B. Chapuis, Y. Chalandon, E. Roosnek, 2003, Leukemia.

Kinetics of disappearance and appearance of isoagglutinins A and B after ABO-incompatible hematopoietic stem cell transplantation

C. Combescure, Y. Chalandon, Nicolas Vuilleumier, 2022, Bone Marrow Transplantation.

The Clinical Relevance of Pre-Formed Anti-HLA and Anti-MICA Antibodies after Cord Blood Transplantation in Children

M. Krajinovic, F. Gumy-Pause, M. Ansari, 2013, PloS one.

Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors – first 10 years of prospective donor follow-up of Swiss donors

J. Tiercy, B. M. Frey, Y. Chalandon, 2022, Bone Marrow Transplantation.

Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study

C. van Delden, N. Vernaz, Y. Chalandon, 2021, Vaccines.

[Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].

I. Yakoub-Agha, D. Blaise, F. Suarez, 2016, Bulletin du cancer.

GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study

Patricia Huezo-Diaz Curtis, M. Krajinovic, M. Ansari, 2017, Oncotarget.

Longitudinal follow-up of body composition in hematopoietic stem cell transplant patients

R. Rizzoli, C. Pichard, R. Miralbell, 2005, Bone Marrow Transplantation.

Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications.

M. Heemskerk, S. Degermann, L. Kaiser, 2006, Blood.

Central nervous system graft-versus-host disease (CNS-GvHD) after allogeneic haematopoietic stem cell transplantation

M. Vargas, Y. Chalandon, F. Simonetta, 2018, BMJ Case Reports.

The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT

A. Gratwohl, A. Tichelli, M. Ansari, 2014, Bone Marrow Transplantation.

Comparing Two Types of Rabbit ATG prior to Reduced Intensity Conditioning Allogeneic Hematopoietic SCT for Hematologic Malignancies

J. Passweg, A. Casini, T. Matthes, 2015, Bone marrow research.

Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation.

H. Baldomero, J. Passweg, S. Buhler, 2021, Blood advances.

Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell Transplantation

C. Dantin, A. Pradier, L. Kaiser, 2020, Frontiers in Immunology.

Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplants

M. Ansari, Y. Chalandon, E. Levrat, 2016, Bone Marrow Transplantation.

Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host disease

M. Docquier, L. Kaiser, S. Cordey, 2021, Microbiome.

Pharmakokinetics of Valganciclovir after AlloSCT: A Fixed Oral Dose Can Be Used for Preemptive Therapy in Patients with Normal Body Weight - Even with Intestinal GVHD.

H. Einsele, G. Ehninger, B. Hertenstein, 2004 .

Benefit of Prestorage Leukocyte Depletion of Single‐Donor Platelet Concentrates

P. Roux‐Lombard, J. Dayer, B. Chapuis, 1999, Vox sanguinis.

Successful treatment of central nervous system lymphoproliferative disorder in a kidney-pancreas and stem cell transplanted patient using intrathecal rituximab

M. Vargas, K. Egervari, K. Hadaya, 2021, BMJ Case Reports.

E119D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A(H1N1)pdm09 Isolate From a Stem-Cell Transplant Recipient.

Tom J. Petty, E. Zdobnov, T. Petty, 2015, The Journal of infectious diseases.

Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance

Y. Daali, M. Ansari, C. Peters, 2017, Therapeutic drug monitoring.

Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.

E. Vellenga, M. Jongen‐Lavrencic, J. Passweg, 2017, Blood.

A rare case of primary cutaneous follicle centre lymphoma presenting as a giant tumour of the scalp and combined with JAK2V617F positive essential thrombocythaemia

C. Prins, T. Lecompte, T. Matthes, 2014, Biomarker Research.

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

M. Labopin, A. Nagler, M. Mohty, 2018, JAMA oncology.

γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia.

O. Hantschel, J. Huelsken, J. Bourquin, 2019, Cancer cell.

g-Catenin-Dependent Signals Maintain BCR-ABL1 B Cell Acute Lymphoblastic Leukemia

O. Hantschel, J. Huelsken, J. Bourquin, 2019 .

Human pegivirus persistence in human blood virome after allogeneic haematopoietic stem-cell transplantation.

E. Zdobnov, M. Docquier, C. Dantin, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Outcome and risk factors for late‐onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation

R. Miralbell, J. Passweg, M. Ansari, 2011, European journal of haematology.

Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients >60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study

S. Iacobelli, D. Hasenclever, M. Mohty, 2022, Blood.

Clinical and biological features of PTPN2-deleted adult and pediatric T-cell acute lymphoblastic leukemia.

J. Cayuela, H. Dombret, A. Baruchel, 2019, Blood advances.

Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.

B. Nadel, H. Dombret, E. Macintyre, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Addition of Rituximab Improves the Outcome of Adult Patients with CD20-Positive, Ph-Negative, B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Results of the Randomized Graall-R 2005 Study

H. Dombret, S. Chevret, P. Chevallier, 2015 .

The Omission of High-Dose Cytarabine during Consolidation Therapy of Ph-Positive ALL Patients Treated with Nilotinib and Low-Intensity Chemotherapy Results in an Increased Risk of Relapses Despite Non-Inferior Levels of Late BCR-ABL1 MRD Response. First Results of the Randomized Graaph-2014 Study

F. Pasquier, E. Clappier, J. Cayuela, 2021, Blood.

Frontline Consolidation with Blinatumomab for High-Risk Philadelphia-Negative Acute Lymphoblastic Adult Patients. Early Results from the Graall-2014-QUEST Phase 2

F. Pasquier, E. Clappier, H. Dombret, 2021, Blood.

Torque Teno Virus Load and Acute Rejection After Orthotopic Liver Transplantation.

N. Mueller, A. Pradier, L. Kaiser, 2017, Transplantation.

Torque teno virus in patients undergoing allogeneic hematopoietic stem cell transplantation for hematological malignancies

A. Pradier, L. Kaiser, Y. Chalandon, 2016, Bone Marrow Transplantation.

Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT

N. Kröger, S. Iacobelli, M. Robin, 2014, Haematologica.

Outcome of patients with T-cell lymphoblastic leukemia or lymphoma: The GRAALL experience

H. Dombret, E. Macintyre, S. Leprêtre, 2007 .

Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party

N. Russell, P. Dreger, N. Ifrah, 2015, Bone Marrow Transplantation.

Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries.

A. Gratwohl, H. Baldomero, J. Passweg, 2013, Swiss medical weekly.

Hodgkin’s lymphoma relapsing after autologous transplantation: allogeneic hematopoietic stem cell transplantation using a strategy of reduced intensity conditioning, and T‐cell depletion with T‐cell add‐back

J. Passweg, Y. Chalandon, E. Roosnek, 2009, European journal of haematology.

Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

J. Bourhis, M. Robin, I. Yakoub-Agha, 2023, American journal of hematology.

Genetic susceptibility to hepatic sinusoidal obstruction syndrome in pediatric patients undergoing HSCT.

M. Krajinovic, D. Sinnett, P. Beaulieu, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia

N. Kröger, M. Robin, I. Yakoub-Agha, 2019, British journal of haematology.

Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion.

C. Dantin, M. Ansari, A. Casini, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party.

M. Labopin, D. Blaise, A. Nagler, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT

M. Robin, I. Yakoub-Agha, J. Byrne, 2022, American journal of hematology.

Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.

H. Baldomero, J. Passweg, T. Pabst, 2018, Swiss medical weekly.

Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.

D. Horsman, D. Hogge, Y. Chalandon, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS

M. Robin, D. Blaise, G. Guillerm, 2023, Bone Marrow Transplantation.

Conditioning‐based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991‐2012) on behalf of EBMT CMWP

N. Kröger, S. Iacobelli, I. Yakoub-Agha, 2019, European journal of haematology.

Dynamics of Expression of Programmed Cell Death Protein-1 (PD-1) on T Cells After Allogeneic Hematopoietic Stem Cell Transplantation

C. Dantin, A. Pradier, Y. Chalandon, 2019, Front. Immunol..

Suggestive evidence of a role of HLA-DRB4 mismatches in the outcome of allogeneic hematopoietic stem cell transplantation with HLA-10/10-matched unrelated donors: a French–Swiss retrospective study

I. Yakoub-Agha, J. Tiercy, F. Barraco, 2015, Bone Marrow Transplantation.

Hierarchical Evaluation of Baseline Poor-Prognosis Factors and Response to Initial Therapy in Younger Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL) Treated in the Risk-Adapted GRAALL-2003 Study.

H. Dombret, E. Macintyre, A. Delannoy, 2005 .

PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.

F. Sigaux, J. Soulier, E. Clappier, 2019, Blood.

Association study of candidate DNA-repair gene variants and acute graft versus host disease in pediatric patients receiving allogeneic hematopoietic stem-cell transplantation

M. Krajinovic, Peter Shaw, F. Gumy-Pause, 2021, The pharmacogenomics journal.

The Upper Age Limit for a Pediatric-Inspired Therapy in Younger Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL)? Analysis of the Graall-2005 Study

H. Dombret, E. Macintyre, S. Leprêtre, 2016 .

Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome

C. Dantin, A. Pradier, Y. Chalandon, 2018, Bone Marrow Transplantation.

Post-artesunate delayed haemolysis ‒ report of four cases and review of the literature.

H. Spechbach, G. Eperon, Y. Chalandon, 2015, Swiss medical weekly.

Towards a Pediatric Approach in Adults with Acute Lymphoblastic Leukemia (ALL): The GRAALL-2003 Study.

H. Dombret, E. Macintyre, A. Delannoy, 2006 .

Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma in Switzerland, 20 years of experience: 2001–2020

H. Baldomero, Y. Chalandon, A. Rovó, 2022, EJHaem.

Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.

D. Rossi, J. Passweg, T. Pabst, 2020, Blood advances.

[Prerequisite for hematopoietic cellular therapy programs to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

I. Yakoub-Agha, J. Larghero, M. Deschamps, 2017, Bulletin du Cancer.

[Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

I. Yakoub-Agha, N. Simon, V. Coiteux, 2017, Bulletin du Cancer.

CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation

Z. Kutalik, F. Ruschitzka, C. Lovis, 2015, The Pharmacogenomics Journal.

Clinical prediction model for prognosis in kidney transplant recipients (KIDMO): study protocol

F. Ruschitzka, N. Mueller, T. Fehr, 2023, Diagnostic and Prognostic Research.

Nutritional support practices in hematopoietic stem cell transplantation centers: A nationwide comparison.

C. Pichard, J. Passweg, T. Pabst, 2017, Nutrition.

Agrobacterium yellow group: bacteremia and possible septic arthritis following peripheral blood stem cell transplantation

D. Roscoe, Y. Chalandon, S. Nantel, 2000, Bone Marrow Transplantation.

Incidence of Acute Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation over Time: A Study from the Transplant Complications and Chronic Malignancies Working Party of the EBMT

S. Montoto, M. Robin, I. Yakoub-Agha, 2018, Blood.

Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation

A. Buckling, L. Farinelli, F. Ruschitzka, 2017, Scientific Reports.

Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma

S. Cordey, A. Poncet, L. Turin, 2023, Viruses.

Bronchiolitis obliterans syndrome following SARS-CoV-2 infection in an allogeneic hematopoietic stem cell recipient

F. Giannotti, C. Tapparel, Anne Bergeron, 2023, American Journal of Transplantation.

Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantation

A. Pradier, S. Cordey, Y. Chalandon, 2023, Frontiers in Immunology.

Disseminated Rhizopus microsporus infection cured by salvage allogeneic hematopoietic stem cell transplantation, antifungal combination therapy, and surgical resection

J. Passweg, C. van Delden, J. Garbino, 2010, Transplant Infectious Disease.

A phase I dose-escalation study of MSC1992371A, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies.

G. Martinelli, F. Giles, J. Duyster, 2013, Leukemia research.

Phase I, Dose-Escalation Study of 2 Dosing Regimens of AS703569, An Inhibitor of Aurora and Other Kinases, Administered Orally in Patients with Advanced Hematological Malignancies

A. Gratwohl, J. Duyster, A. Gianella-Borradori, 2008 .

Real-world experience of sorafenib maintenance after allogeneic hematopoietic stem cell transplantation for FLT3-ITD AML reveals high rates of toxicity-related treatment interruption

A. Pradier, F. Giannotti, Y. Chalandon, 2020, Frontiers in Oncology.

Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in Polycythemia Vera and Essential Thrombocythemia Myelofibrosis after Allogeneic Stem Cell Transplantation.

J. Bourhis, R. Fanin, N. Kröger, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT

J. Passweg, L. Kaiser, Y. Thomas, 2011, Bone Marrow Transplantation.

Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index

C. Dantin, M. Ansari, Y. Chalandon, 2016, Bone Marrow Transplantation.

hematopoietic cells controls lineage programming Modulation of p210BCR-ABL activity in transduced primary human

C. Eaves, G. Hazlewood, Xiaoyan Jiang, 2013 .

Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis

N. Schmitz, I. Yakoub-Agha, P. Dreger, 2023, Leukemia.

Prevention of Venous Thrombotic Events in Adult Patients with Acute Lymphoblastic Leukemia Treated in a Pediatric-Inspired Protocol - a Graall Study

H. Dombret, P. Chevallier, T. Pabst, 2016 .

Efficient Prophylaxis with Defibrotide for Sinusoidal Obstruction Syndrome (SOS) after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

C. Dantin, M. Ansari, Y. Chalandon, 2016 .

DONOR LYMPHOCYTE INFUSIONS INDUCE DURABLE RESPONSES IN PATIENTS WITH FOLLICULAR, MANTLE AND T CELL LYMPHOMAS RELAPSING AFTER AN ALLOSCT. AN EBMT‐LWP STUDY

N. Schmitz, S. Montoto, P. Dreger, 2019, Hematological Oncology.

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adults With Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL): Results From The Group For Research On Adult ALL (GRAALL)

H. Dombret, P. Chevallier, D. Blaise, 2013 .

Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine

M. Jongen‐Lavrencic, T. Pabst, G. Ossenkoppele, 2023, Blood cancer journal.

Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high‐risk hematopoietic cell transplant recipients

C. van Delden, Y. Chalandon, S. Masouridi-Levrat, 2021, Immunity, inflammation and disease.

GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation

M. Krajinovic, M. Ansari, H. Bittencourt, 2021, Journal of Cancer Research and Clinical Oncology.

GSTM1 and GSTT1 Double Null Genotypes Determining Cell Fate and Proliferation as Potential Risk Factors of Relapse in Children with Hematological Malignancies after Stem Cell Transplantation.

M. Krajinovic, M. Ansari, H. Bittencourt, 2021 .

Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts

F. Giannotti, Y. Chalandon, S. Masouridi-Levrat, 2020 .

Computed tomography derived liver volume: a prognostic factor in decompensated alcoholic cirrhosis?

N. Lanthier, S. Terraz, L. Spahr, 2013 .

119 D Neuraminidase Mutation Conferring Pan-Resistance to Neuraminidase Inhibitors in an A ( H 1 N 1 ) pdm 09 Isolate From a Stem-Cell Transplant Recipient

E. Zdobnov, T. Petty, G. Boivin, 2015 .

Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: Case report and review of the literature

C. van Delden, M. Bongiovanni, J. Pache, 2007, Scandinavian journal of infectious diseases.

Rhinovirus Infections among Hematopoietic Stem Cell Transplant Recipients: A Pre-Transplant Dilemma?

C. Dantin, L. Kaiser, Y. Chalandon, 2022, Viruses.

T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients

J. Tamburini, A. Pradier, Y. Chalandon, 2022, Annals of Oncology.

Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates

N. Mueller, J. Passweg, M. Weisser, 2022, Bone Marrow Transplantation.

Intracellular Pathogen in the Cerebrospinal Fluid of an Allogeneic Hematopoietic Cell Transplant Recipient With Graft-Versus-Host Disease and Brain Lesions.

C. van Delden, Y. Chalandon, S. Masouridi-Levrat, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study

F. Ruschitzka, C. Lovis, N. Mueller, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

The MELD upgrade exception: a successful strategy to optimize access to liver transplantation for patients with high waiting list mortality.

Brian J. Lang, F. Ruschitzka, C. Lovis, 2021, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome – positive acute lymphoblastic leukemia : results of the GRAAPH-2003 study

J. Cayuela, H. Dombret, E. Macintyre, 2007 .

CMV Infection After Letermovir Primary Prophylaxis Discontinuation in Allogeneic Hematopoietic Cell Transplant Recipients

F. Giannotti, C. van Delden, Y. Chalandon, 2023, Open Forum Infectious Diseases.

Clostridium difficile infection is associated with graft loss in solid organ transplant recipients

F. Ruschitzka, C. Lovis, N. Mueller, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?

F. Giannotti, C. van Delden, Y. Chalandon, 2022, Mycoses.

SARS-CoV-2 m-RNA Vaccine Response in Immunocompromised Patients: A Monocentric Study Comparing Cancer, People Living with HIV, Hematopoietic Stem Cell Transplant Patients and Lung Transplant Recipients

S. Yerly, A. Addeo, A. Calmy, 2023, Vaccines.

High hyperdiploid acute lymphoblastic leukemia in adults shows clonal heterogeneity and chromosomal instability at diagnosis and during the course of the disease

A. Marazzi, A. Tichelli, Y. Chalandon, 2012, Annals of Hematology.

Analysis of T cell Repertoire and Transcriptome Identifies Mechanisms of Regulatory T cell (Treg) Suppression of GvHD.

A. Pradier, S. Buhler, R. Negrin, 2022, Blood.

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome – positive acute lymphoblastic leukemia : results of the GRAAPH-2003 study

J. Cayuela, H. Dombret, E. Macintyre, 2007 .

Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant Recipients

N. Mueller, J. Passweg, C. van Delden, 2020, Open forum infectious diseases.

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

J. Cayuela, H. Dombret, E. Macintyre, 2007, Blood.

Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.

H. Dombret, S. Chevret, P. Chevallier, 2016, The New England journal of medicine.

Development of an integrated model of care for allogeneic stem cell transplantation facilitated by eHealth—the SMILe study

F. Dobbels, J. Passweg, T. Schulz, 2021, Supportive Care in Cancer.

Impact of central nervous system involvement in adult patients with Philadelphia-negative acute lymphoblastic leukemia: a GRAALL-2005 study.

H. Dombret, S. Leprêtre, P. Chevallier, 2023, Haematologica.

Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan

J. Passweg, M. Ansari, D. Heim, 2023, Bone Marrow Transplantation.

GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study

Patricia Huezo-Diaz Curtis, M. Krajinovic, M. Ansari, 2017, Oncotarget.

Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMT.

M. Voso, M. Robin, M. Wlodarski, 2023, The Lancet. Haematology.

[Indications and management of hematologic microtransplantation: Recommendations of the French Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].

P. Chevallier, I. Yakoub-Agha, C. Picard, 2020, Bulletin du cancer.

J. Passweg, Y. Chalandon, E. Roosnek, 2009, European journal of haematology.

Graft-versus-Host Disease Prophylaxis with Post Transplant Cyclophosphamide in Chronic Myeloid Leukemia patients undergoing Allogeneic Hematopoietic Cell Transplant from either an Unrelated or Mismatched Related Donor: a comparative study from the Chr....

I. Yakoub-Agha, D. Mclornan, L. Griškevičius, 2023, Transplantation and cellular therapy.

The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCT

A. Gratwohl, R. Seger, Y. Chalandon, 2014, Bone Marrow Transplantation.

Long-term follow-up of the imatinib GRAAPH-2003 study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study.

J. Cayuela, H. Dombret, M. Vekemans, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Frequency and Outcome of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with BCR-ABL1 Clonal Hematopoiesis after Blast Clearance: Results from the Graaph-2014 Trial

J. Soulier, E. Clappier, J. Cayuela, 2021, Blood.

High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study.

V. V. D. van der Velden, M. Vekemans, J. Passweg, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.

M. Carrington, E. Tholouli, C. Crawley, 2019, The Lancet. Haematology.

Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis

J. Soulier, E. Clappier, H. Dombret, 2023, Blood cancer discovery.

Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018

N. Mueller, O. Manuel, K. Boggian, 2021, Antimicrobial Resistance & Infection Control.

Minimal Residual Disease-Negative Complete Remission at the End of Induction Is a Prognostic Indicator of Long-Term Survival in Adult Patients with Ph+ Acute Lymphoblastic Leukemia Receiving First-Line Therapy

H. Dombret, H. Kantarjian, E. Jabbour, 2023, Blood.

Salvage Treatment of Refractory HSV Oral Lesions with Pritelivir in Allogeneic Hematopoietic Cell Transplant Recipients

F. Giannotti, Y. Chalandon, S. Masouridi-Levrat, 2023, Antimicrobial agents and chemotherapy.

Outcomes of CMML patients undergoing allo‐HCT are significantly worse compared to MDS—a study of the CMWP of the EBMT

M. Robin, G. Kobbe, A. Radujkovic, 2023, American journal of hematology.

Atypical pulmonary phaeohyphomycosis due to Aureobasidium spp. - case report and brief literature review.

C. De Vito, Y. Chalandon, D. Spoerl, 2022, Swiss medical weekly.

Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

N. Kröger, M. Robin, I. Yakoub-Agha, 2018, British journal of haematology.

N. Kröger, J. Sierra, M. Robin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.